WHO ICTRP trial
Prucalopride for minimizing bowel ileus following ERCP with CO2 insufflation: A…
TCTR20210814001 · Thai Clinical Trials Registry (TCTR) · Recruiting
Key facts
| Trial ID | TCTR20210814001 |
|---|---|
| Public title | Prucalopride for minimizing bowel ileus following ERCP with CO2 insufflation: A prospective randomize double-blinded placebo controlled trial |
| Scientific title | Prucalopride for minimizing bowel ileus following ERCP with CO2 insufflation: A prospective randomize double-blinded placebo controlled trial |
| Primary sponsor | Srinagarind Hospital Khonkaen University |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Thailand |
| Conditions | Must have provided written informed consent prior to any screening procedures. Male/female patients between 18 to 65 years of age at the time of informed consent who visit the clinic for having ERCP procedure. ERCP ;ERCP |
| Interventions | Prucalopride 2 mg oral before ERCP 2 hour,Placebo 1 tab oral before ERCP 2 hour;Active Comparator Drug,Placebo Comparator Drug;Prucalopride,Placebo |
| Registration date | Aug 14, 2021 |
| Target size | 194 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: